Additional Copies of 1q Negatively Impact the Outcome of Multiple Myeloma Patients and Induce Transcriptomic Deregulation in Malignant Plasma Cells

0
16
Investigators evaluated the impact of Amp1q/Gain1q on the outcome of newly diagnosed multiple myeloma patients enrolled in the FORTE trial.
[Blood Cancer Journal]
Full Article